ArticleJournal of medicinal chemistry2022

Discovery of Orally Bioavailable and Brain-Penetrable Prodrugs of the Potent nSMase2 Inhibitor DPTIP.

Arindom Pal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.